Your shopping cart is currently empty

Anticancer agent 74 exhibits moderate anticancer activity with lower selectivity and cytotoxicity compared to doxorubicin towards normal cells [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | Anticancer agent 74 exhibits moderate anticancer activity with lower selectivity and cytotoxicity compared to doxorubicin towards normal cells [1]. |
| In vitro | Anticancer agent 74 exhibits low cytotoxicity in HepG2 (IC 50 : 72.27 μM), A549 (IC 50 : 70.79 μM), HuCCA-1 (IC 50 : 70.42 μM), and MOLT-3 (IC 50 : 20.71 μM) cell lines, alongside low selectivity with IC 50 values of 0.88 μM for HepG2, 5.08 μM for A549, 5.11 μM for HuCCA-1, and 17.39 μM for MOLT-3, respectively [1]. Despite its good cytotoxic effects, the compound demonstrates low selectivity across these primary cancer cell types, as assessed in cytotoxicity assays involving the A549, HuCCA-1, HepG2, and MOLT-3 cell lines. |
| Molecular Weight | 351.44 |
| Formula | C25H21NO |
| Cas No. | 2242503-82-6 |
| Smiles | O(CC1=CC=CC=C1)C2=C3C(=C4C(=NC3=CC=C2)CCC4)C5=CC=CC=C5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.